These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36605847)

  • 61. Tumor lysis syndrome: new challenges and recent advances.
    Wilson FP; Berns JS
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):18-26. PubMed ID: 24359983
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Excessive elevation of serum phosphate during tumor lysis syndrome: Lessons from a particularly challenging case.
    Amaechi PK; Jenssen F; Krishnasami Z; Achanti A; Fülöp T
    Clin Nephrol Case Stud; 2021; 9():39-44. PubMed ID: 33884255
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Rasburicase versus allopurinol in the treatment of hyperuricaemia in tumour lysis syndrome].
    Tatay VS; Castilla JD; Ponce JM; Hurtado JM; Cantero E; Abril ML
    An Pediatr (Barc); 2010 Feb; 72(2):103-10. PubMed ID: 20022572
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumor lysis syndrome in solid tumors.
    Mott FE; Esana A; Chakmakjian C; Herrington JD
    Support Cancer Ther; 2005 Apr; 2(3):188-91. PubMed ID: 18628171
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of tumor lysis syndrome with the highest known uric acid level.
    Ozkan G; Ulusoy S; Sönmez M; Kaynar K; Karagülle M
    Ren Fail; 2010; 32(7):895-8. PubMed ID: 20662707
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spontaneous Tumor Lysis Syndrome in an Adenocarcinoma of Unknown Origin.
    Kalter JA; Allen J; Yang Y; Willing T; Evans E
    Cureus; 2020 Dec; 12(12):e12169. PubMed ID: 33489580
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rasburicase: a new approach for preventing and/or treating tumor lysis syndrome.
    Bessmertny O; Robitaille LM; Cairo MS
    Curr Pharm Des; 2005; 11(32):4177-85. PubMed ID: 16375739
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumor lysis syndrome in elderly.
    Pumo V; Sciacca D; Malaguarnera M
    Crit Rev Oncol Hematol; 2007 Oct; 64(1):31-42. PubMed ID: 17658268
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Carfilzomib-associated tumor lysis syndrome.
    Shely RN; Ratliff PD
    Pharmacotherapy; 2014 May; 34(5):e34-7. PubMed ID: 24390940
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.
    Cortes J; Moore JO; Maziarz RT; Wetzler M; Craig M; Matous J; Luger S; Dey BR; Schiller GJ; Pham D; Abboud CN; Krishnamurthy M; Brown A; Laadem A; Seiter K
    J Clin Oncol; 2010 Sep; 28(27):4207-13. PubMed ID: 20713865
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
    Vadhan-Raj S; Fayad LE; Fanale MA; Pro B; Rodriguez A; Hagemeister FB; Bueso-Ramos CE; Zhou X; McLaughlin PW; Fowler N; Shah J; Orlowski RZ; Samaniego F; Wang M; Cortes JE; Younes A; Kwak LW; Sarlis NJ; Romaguera JE
    Ann Oncol; 2012 Jun; 23(6):1640-5. PubMed ID: 22015451
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The management of tumor lysis syndrome.
    Rampello E; Fricia T; Malaguarnera M
    Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Avoiding dialysis in tumour lysis syndrome: is urate oxidase effective? - a case report and review of literature.
    Teo WY; Loh TF; Tan AM
    Ann Acad Med Singap; 2007 Aug; 36(8):679-83. PubMed ID: 17767339
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tumor Lysis Syndrome in Patients with Hematological Malignancies.
    Belay Y; Yirdaw K; Enawgaw B
    J Oncol; 2017; 2017():9684909. PubMed ID: 29230244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006945. PubMed ID: 28272834
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tumour lysis syndrome in children: experience of last decade.
    Ahn YH; Kang HJ; Shin HY; Ahn HS; Choi Y; Kang HG
    Hematol Oncol; 2011 Dec; 29(4):196-201. PubMed ID: 21710502
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Acute renal failure in patients with tumour lysis sindrome].
    Poskurica M; Petrović D; Poskurica M
    Srp Arh Celok Lek; 2016; 144(3-4):232-9. PubMed ID: 27483573
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment Regimens.
    Weeks AC; Kimple ME
    J Investig Med High Impact Case Rep; 2015; 3(3):2324709615603199. PubMed ID: 26904699
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of impending tumor lysis with single-dose rasburicase.
    Lee AC; Li CH; So KT; Chan R
    Ann Pharmacother; 2003 Nov; 37(11):1614-7. PubMed ID: 14565793
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function.
    Malaguarnera M; Vacante M; Russo C; Dipasquale G; Gargante MP; Motta M
    Expert Opin Pharmacother; 2009 Apr; 10(5):737-42. PubMed ID: 19351224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.